Steven E. Shoelson, M.D., Ph.D.
Title Professor of Medicine Institution Joslin Diabetes Center Address Joslin Diabetes Center Research Division One Joslin Place Boston MA 02215
|
|
Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
R01DK112153
(SHOELSON, STEVEN E)
May 2, 2018 - Mar 31, 2022
Feeding Drives HSF1 Transcriptional Programs Required for Global Protein Synthesis
Role: Principal Investigator
-
R01HL133329
(SHOELSON, STEVEN E)
May 20, 2016 - Mar 31, 2020
Intrinsic anti-inflammatory actions of AMPK activation rendered through a novel immunometabolic AMPK-mTOR-NFkB Pathway
Role: Principal Investigator
-
R01DK108936
(SHOELSON, STEVEN E)
May 16, 2016 - Mar 31, 2020
Xanthine oxidase inhibition raises intracellular purines to activate AMPK, improve glucose control and decrease fatty liver and atherosclerosis in type 2 diabetes
Role: Principal Investigator
-
R01DK095327
(SHOELSON, STEVEN E)
Apr 1, 2014 - Mar 31, 2018
Targeting Neutrophils and Leukotrienes to Treat Type 2 Diabetes
Role: Principal Investigator
-
RC4DK090792
(SHOELSON, STEVEN E)
Sep 30, 2010 - Sep 29, 2012
Mechanism-Based Biomarkers for Glucose-Lowering in TINSAL-T2D
Role: Principal Investigator
-
U01DK074556
(SHOELSON, STEVEN E)
Sep 4, 2006 - Jun 30, 2013
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Role: Principal Investigator
-
P50HL083813
(WELTY, FRANCINE K)
May 1, 2006 - May 31, 2015
Metabolic Syndrome, Inflammation and Vascular Remodeling
Role: Co-Principal Investigator
-
R01DK073547
(SHOELSON, STEVEN E)
Feb 15, 2006 - Jun 30, 2011
TOLL RECEPTOR ACTIVATION OF NF-kB IN INSULIN RESISTANCE AND T2DM
Role: Principal Investigator
-
R37DK051729
(SHOELSON, STEVEN E)
Sep 21, 1996 - Jun 30, 2011
Mediators and Modifiers of NF-kappaB in Insulin Resistance
Role: Principal Investigator
-
R01DK051729
(SHOELSON, STEVEN E)
Sep 21, 1996 - Aug 31, 2005
IKK MEDIATED INSULIN RESISTANCE AND IN VIVO REVERSAL
Role: Principal Investigator
-
R01DK045943
(SHOELSON, STEVEN E)
Aug 1, 1996 - Dec 31, 2010
EFFECTS OF IKKB and NFkB IN INSULIN RESISTANCE
Role: Principal Investigator
-
R01DK043123
(SHOELSON, STEVEN E)
Sep 30, 1992 - Dec 31, 2009
Ser/Thr Phosphorylation in Insulin Resistance
Role: Principal Investigator
-
P30DK036836
(KING, GEORGE L)
Sep 30, 1986 - Mar 31, 2027
Role: Co-Principal Investigator
-
M01RR002635
(GOTTLIEB, GARY L)
Dec 1, 1984 - Mar 31, 2010
General Clinical Research Center
Role: Co-Principal Investigator
-
M01RR001032
(SUKHATME, VIKAS P)
Dec 1, 1977 - Mar 31, 2010
General Clinical Research Center
Role: Co-Principal Investigator
Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.